tradingkey.logo

Bionano Genomics Inc

BNGO
View Detailed Chart

3.040USD

+0.090+3.05%
Market hours ETQuotes delayed by 15 min
9.43MMarket Cap
LossP/E TTM

Bionano Genomics Inc

3.040

+0.090+3.05%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.05%

5 Days

-10.06%

1 Month

-9.80%

6 Months

-42.64%

Year to Date

-82.43%

1 Year

-90.81%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts
BUY
Current Rating
7.333
Target Price
148.59%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
Bionano Genomics Inc
BNGO
4
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(10)
Neutral(0)
Buy(0)
Indicators
Sell(4)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.091
Sell
RSI(14)
25.094
Sell
STOCH(KDJ)(9,3,3)
5.172
Oversold
ATR(14)
0.131
High Vlolatility
CCI(14)
-161.016
Sell
Williams %R
95.544
Oversold
TRIX(12,20)
-0.258
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
3.066
Sell
MA10
3.269
Sell
MA20
3.322
Sell
MA50
3.447
Sell
MA100
3.569
Sell
MA200
7.840
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Ticker SymbolBNGO
CompanyBionano Genomics Inc
CEODr. R. Erik Holmlin, Ph.D.
Websitehttps://bionano.com/
KeyAI